Loading...
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
Pancreatic cancer is arguably the deadliest cancer type. The efficacy of current therapies is often hindered by the inability to predict patient outcome. As such, the development of tools for early detection and risk prediction is key for improving outcome and quality of life. Here, we introduce the...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6210040/ https://ncbi.nlm.nih.gov/pubmed/30009399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12356 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|